P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-10-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000890584.35232.1f |
| _version_ | 1797281350280019968 |
|---|---|
| author | Simonetta Viviani Chiara Pavoni Sally F. Barrington Luca Guerra Heiko Schöder Peter Johnson Amy A. Kirkwood Deborah M. Stephens Jonathan W. Friedberg Stephane Chauvie Michael V. Knopp Massimo Federico Gunilla Enblad Paolo Corradini Andrea Gallamini Alessandro Rambaldi Corrado Tarella |
| author_facet | Simonetta Viviani Chiara Pavoni Sally F. Barrington Luca Guerra Heiko Schöder Peter Johnson Amy A. Kirkwood Deborah M. Stephens Jonathan W. Friedberg Stephane Chauvie Michael V. Knopp Massimo Federico Gunilla Enblad Paolo Corradini Andrea Gallamini Alessandro Rambaldi Corrado Tarella |
| author_sort | Simonetta Viviani |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:55:16Z |
| format | Article |
| id | doaj.art-ba8e0edd18e44f9a9dd3537d5e00c794 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:55:16Z |
| publishDate | 2022-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-ba8e0edd18e44f9a9dd3537d5e00c7942024-03-03T04:22:34ZengWileyHemaSphere2572-92412022-10-0162310.1097/01.HS9.0000890584.35232.1f202210005-00004P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trialsSimonetta Viviani0Chiara Pavoni1Sally F. Barrington2Luca Guerra3Heiko Schöder4Peter Johnson5Amy A. Kirkwood6Deborah M. Stephens7Jonathan W. Friedberg8Stephane Chauvie9Michael V. Knopp10Massimo Federico11Gunilla Enblad12Paolo Corradini13Andrea Gallamini14Alessandro Rambaldi15Corrado Tarella161 Division of Onco-Hematology, European Institute of Oncology, IRCCS, Milan3 Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy4 King’s College London and Guy’s and St Thomas’ PET Centre, School of Biomedical Engineering and Imaging Sciences, King’s College London, King’s Health Partners, London.5 School of Medicine and Surgery, University of Milano-Bicocca7 Memorial Sloan Kettering Cancer Center, New York, NY,USA8 Cancer Research UK Centre, University of Southampton, UK.9 Cancer Research UK and University College London Cancer Trials Centre, University College London, London10 Division of Hematology, University of Utah, Salt Lake City, UT.11 Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY.12 Medical Physics Division, Santa Croce e Carle Hospital, Cuneo, Italy13 Department of Radiology, Wright Center of Innovation in Biomedical Imaging, The Ohio State University Wexner Medical Center, Columbus, USA14 CHIMOMO department, University of Modena and Reggio Emilia, Policlinico, Modena, Italy15 Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory C11, Uppsala, Sweden2 Ematologia, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan17 Research and Innovation Department, A. Lacassagne Cancer Center, Nice, France18 Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo20 Division of Onco-Hematology, European Institute of Oncology, IRCCS, Milan: Dipartimento Universitario di Scienze della Salute (DISS), Universita’ di Milano, Italyhttp://journals.lww.com/10.1097/01.HS9.0000890584.35232.1f |
| spellingShingle | Simonetta Viviani Chiara Pavoni Sally F. Barrington Luca Guerra Heiko Schöder Peter Johnson Amy A. Kirkwood Deborah M. Stephens Jonathan W. Friedberg Stephane Chauvie Michael V. Knopp Massimo Federico Gunilla Enblad Paolo Corradini Andrea Gallamini Alessandro Rambaldi Corrado Tarella P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials HemaSphere |
| title | P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials |
| title_full | P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials |
| title_fullStr | P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials |
| title_full_unstemmed | P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials |
| title_short | P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials |
| title_sort | p004 advanced stage classical hodgkin lymphoma chl patients with a positive interim pet pet 2 deauville score ds 5 after 2 abvd cycles a pooled analysis of individual patient data of three multicenter trials |
| url | http://journals.lww.com/10.1097/01.HS9.0000890584.35232.1f |
| work_keys_str_mv | AT simonettaviviani p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT chiarapavoni p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT sallyfbarrington p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT lucaguerra p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT heikoschoder p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT peterjohnson p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT amyakirkwood p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT deborahmstephens p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT jonathanwfriedberg p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT stephanechauvie p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT michaelvknopp p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT massimofederico p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT gunillaenblad p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT paolocorradini p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT andreagallamini p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT alessandrorambaldi p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials AT corradotarella p004advancedstageclassicalhodgkinlymphomachlpatientswithapositiveinterimpetpet2deauvillescoreds5after2abvdcyclesapooledanalysisofindividualpatientdataofthreemulticentertrials |